JCT> Vol.2 No.5, December 2011

 

Copyright © 2011 Daniel Oruzio, Günter Waxenecker, Christoph Aulmann, Bruno Märkl, Theodor Wagner, Geert Mudde, Manfred Schuster, Norbert Eller, Andrea Mayer, Stefan Stranner, Gottfried Himmler, Hans Loibner, Günter Schlimok, Ralf Kircheis, Andreas Nechansky et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

 

How to Cite this Article

---

D. Oruzio, G. Waxenecker, C. Aulmann, B. Märkl, T. Wagner, G. Mudde, M. Schuster, N. Eller, A. Mayer, S. Stranner, G. Himmler, H. Loibner, G. Schlimok, R. Kircheis and A. Nechansky, "Phase I Dose Escalation Study with the Lewis Y Carbohydrate Specific Humanized Antibody IGN311," Journal of Cancer Therapy, Vol. 2 No. 5, 2011, pp. 760-771. doi: 10.4236/jct.2011.25102.

 

Download citation as EndNote